https://www.pharmaglobenewswire.com/fda-approves-zycubo-for-menkes-disease/ 2026-01-21T05:44:03+00:00 https://www.pharmaglobenewswire.com/fda-grants-breakthrough-therapy-designation-to-privosegtor-for-optic-neuritis/ 2026-01-21T05:23:15+00:00 https://www.pharmaglobenewswire.com/fda-approves-agios-aqvesme-for-thalassemia/ 2026-01-21T05:09:11+00:00 https://www.pharmaglobenewswire.com/chronic-refractory-cough-market/ 2026-01-21T04:09:53+00:00 https://www.pharmaglobenewswire.com/cipn-market-size-was-around-usd-1500-million-in-2023/ 2026-01-21T03:35:22+00:00 https://www.pharmaglobenewswire.com/geographic-atrophy-market-size/ 2026-01-21T01:45:22+00:00 https://www.pharmaglobenewswire.com/sickle-cell-disease-market-size/ 2026-01-20T19:11:02+00:00 https://www.pharmaglobenewswire.com/philips-advances-cardiac-mr-with-ai/ 2025-12-08T09:27:02+00:00 https://www.pharmaglobenewswire.com/genprex-adds-new-clinical-trial-site-for-acclaim-1-and-acclaim-3-lung-cancer-studies/ 2025-12-01T11:04:45+00:00 https://www.pharmaglobenewswire.com/soligenix-hits-key-enrollment-milestone-in-phase-3-trial-for-hybryte-in-cutaneous-t-cell-lymphoma/ 2025-12-01T11:03:12+00:00 https://www.pharmaglobenewswire.com/strong-interim-results-from-protaras-tara%e2%80%91002-in-pediatric-lymphatic-malformations/ 2025-12-01T07:44:32+00:00 https://www.pharmaglobenewswire.com/poherdy-gains-fda-approval-a-new-biosimilar-for-her2%e2%80%91positive-breast-cancer/ 2025-12-01T07:39:44+00:00 https://www.pharmaglobenewswire.com/global-ai-in-medical-diagnostics-market-set-for-exceptional-growth-at-a-cagr-of-22-by-2032-delveinsight/ 2025-12-01T06:01:47+00:00 https://www.pharmaglobenewswire.com/fda-approves-johnson-johnson-darzalex-faspro-for-high-risk-multiple-myeloma/ 2025-11-28T06:23:12+00:00 https://www.pharmaglobenewswire.com/fda-approves-astrazeneca-koselugo-for-nf1-pn/ 2025-11-28T06:16:35+00:00 https://www.pharmaglobenewswire.com/fda-approves-amgen-imdelltra-for-extensive-stage-small-cell-lung-cancer-treatment/ 2025-11-28T06:10:30+00:00 https://www.pharmaglobenewswire.com/fda-approves-mercks-keytruda-and-keytruda-qlex-in-combination-with-astellas-pharmas-padcev-as-perioperative-treatment-for-muscle-invasive-bladder-cancer/ 2025-11-28T06:05:17+00:00 https://www.pharmaglobenewswire.com/novartis-receives-fda-approval-for-itvisma-gene-replacement-therapy-in-spinal-muscular-atrophy/ 2025-11-28T05:55:43+00:00 https://www.pharmaglobenewswire.com/fda-approves-astrazeneca-durvalumab-imfinzi/ 2025-11-27T05:17:21+00:00 https://www.pharmaglobenewswire.com/voyxact-fda-approval-igan-treatment-landscape/ 2025-11-27T05:04:00+00:00 https://www.pharmaglobenewswire.com/global-oxygen-therapy-equipment-market-expected-to-grow-at-8-cagr-by-2032-driven-by-increasing-respiratory-disorders-and-technological-advancements-delveinsight/ 2025-11-20T12:22:34+00:00 https://www.pharmaglobenewswire.com/food-allergy-market-worth-usd-3-billion-across-the-7mm-anticipated-to-grow-at-a-cagr-of-11-3-by-2034-delveinsight/ 2025-11-20T12:19:02+00:00 https://www.pharmaglobenewswire.com/choroidal-neovascularization-market-expected-to-experience-rapid-growth-during-2025-2034-driven-by-advancements-in-anti-vegf-therapies-delveinsight/ 2025-11-20T12:16:00+00:00 https://www.pharmaglobenewswire.com/global-pain-management-devices-market-poised-for-rapid-growth-at-a-cagr-of-8-by-2032-driven-by-rising-demand-for-minimally-invasive-solutions-delveinsight/ 2025-11-20T12:09:04+00:00 https://www.pharmaglobenewswire.com/androgen-receptor-targeted-therapies-market-outlook-key-trends-and-growth-forecast-across-the-7mm-2025-2034-delveinsight/ 2025-11-20T12:06:26+00:00 https://www.pharmaglobenewswire.com/global-pharmaceutical-contract-manufacturing-market-expected-to-exceed-usd-360-billion-by-2032-delveinsight/ 2025-11-20T12:06:00+00:00 https://www.pharmaglobenewswire.com/ph-ild-market-size/ 2025-11-20T11:35:50+00:00 https://www.pharmaglobenewswire.com/global-digital-biomarkers-market-expected-to-witness-strong-growth-with-a-cagr-of-17-by-2032-delveinsight/ 2025-11-20T11:35:25+00:00 https://www.pharmaglobenewswire.com/diffuse-large-b-cell-lymphoma-market-projected-to-expand-at-a-cagr-of-13-by-2034-across-key-markets-us-eu4-uk-and-japan-delveinsight/ 2025-11-20T11:34:28+00:00 https://www.pharmaglobenewswire.com/mydriasis-market-to-reach-new-heights-in-growth-by-2034-delveinsight-predicts/ 2025-11-20T11:33:14+00:00 https://www.pharmaglobenewswire.com/cataract-surgery-complications-market-outlook-to-2034-key-trends-growth-drivers-and-forecast-analysis-delveinsight/ 2025-11-20T08:08:41+00:00 https://www.pharmaglobenewswire.com/global-cataract-surgery-devices-market-to-grow-at-a-cagr-of-5-07-by-2032-delveinsight/ 2025-11-19T12:21:33+00:00 https://www.pharmaglobenewswire.com/marginal-zone-lymphoma-pipeline-2025-fda-updates-therapy-innovations-and-clinical-trial-landscape-delveinsight/ 2025-11-19T12:16:58+00:00 https://www.pharmaglobenewswire.com/clostridium-difficile-infections-pipeline-2025-latest-fda-approvals-clinical-trials-and-emerging-therapies-delveinsight/ 2025-11-19T12:07:21+00:00 https://www.pharmaglobenewswire.com/egfr-inhibitor-market-expected-to-gain-momentum-through-2034-according-to-delveinsight/ 2025-11-19T11:58:04+00:00 https://www.pharmaglobenewswire.com/myelofibrosis-market-size-2/ 2025-11-19T10:46:11+00:00 https://www.pharmaglobenewswire.com/kras-inhibitors-market-size/ 2025-11-19T09:02:40+00:00 https://www.pharmaglobenewswire.com/npc-market-size/ 2025-11-19T07:50:47+00:00 https://www.pharmaglobenewswire.com/tnbc-market-size/ 2025-11-19T07:32:02+00:00 https://www.pharmaglobenewswire.com/ncfb-market-size/ 2025-11-19T07:28:13+00:00